Selected research
Industry Research
Lactulose Oral Solution Industry Research Report 2026
Market perspective
The global Lactulose Oral Solution market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lactulose Oral Solution is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lactulose Oral Solution is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lactulose Oral Solution is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lactulose Oral Solution include Abbott, Sanofi, Dandong Kangfu, Trumac Healthcare, Solvay Group(Solvay Pharmaceuticals), Rompharm Company, Merro Pharmaceutical, Incepta Pharmaceuticals Ltd. and Illovo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lactulose Oral Solution market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lactulose Oral Solution Market by Company
Abbott
Sanofi
Dandong Kangfu
Trumac Healthcare
Solvay Group(Solvay Pharmaceuticals)
Rompharm Company
Merro Pharmaceutical
Incepta Pharmaceuticals Ltd.
Illovo
Biofac
Aristopharma LTD
Arecor Therapeutics (Tetris Pharma)
Akorn Operating Company
Lactulose Oral Solution Segment by Type
1000 ML
200 ML
300 ML
500 ML
Others
Lactulose Oral Solution Segment by Application
Infants and Children Under 6 Years
Adults and Children Aged More Than 14 years
Children Aged 6-14 Years
Lactulose Oral Solution Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lactulose Oral Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lactulose Oral Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lactulose Oral Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lactulose Oral Solution manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lactulose Oral Solution by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lactulose Oral Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1000 ML
- 200 ML
- 300 ML
- 500 ML
- Others
Applications
- Infants and Children Under 6 Years
- Adults and Children Aged More Than 14 years
- Children Aged 6-14 Years
Companies covered
- Abbott
- Sanofi
- Dandong Kangfu
- Trumac Healthcare
- Solvay Group(Solvay Pharmaceuticals)
- Rompharm Company
- Merro Pharmaceutical
- Incepta Pharmaceuticals Ltd.
- Illovo
- Biofac
- Aristopharma LTD
- Arecor Therapeutics (Tetris Pharma)
- Akorn Operating Company
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lactulose Oral Solution Market Size (2021-2032)
- 2.2.2 Global Lactulose Oral Solution Sales (2021-2032)
- 2.2.3 Global Lactulose Oral Solution Market Average Price (2021-2032)
- 2.3 Lactulose Oral Solution by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1000 ML
- 2.3.3 200 ML
- 2.3.4 300 ML
- 2.3.5 500 ML
- 2.3.6 Others
- 2.4 Lactulose Oral Solution by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Infants and Children Under 6 Years
- 2.4.3 Adults and Children Aged More Than 14 years
- 2.4.4 Children Aged 6-14 Years
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lactulose Oral Solution Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lactulose Oral Solution Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lactulose Oral Solution Revenue of Manufacturers (2021-2026)
- 3.4 Global Lactulose Oral Solution Average Price by Manufacturers (2021-2026)
- 3.5 Global Lactulose Oral Solution Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lactulose Oral Solution, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lactulose Oral Solution, Product Type & Application
- 3.8 Global Manufacturers of Lactulose Oral Solution, Established Date
- 3.9 Global Lactulose Oral Solution Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott Lactulose Oral Solution Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Lactulose Oral Solution Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Dandong Kangfu
- 4.3.1 Dandong Kangfu Company Information
- 4.3.2 Dandong Kangfu Business Overview
- 4.3.3 Dandong Kangfu Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dandong Kangfu Lactulose Oral Solution Product Portfolio
- 4.3.5 Dandong Kangfu Recent Developments
- 4.4 Trumac Healthcare
- 4.4.1 Trumac Healthcare Company Information
- 4.4.2 Trumac Healthcare Business Overview
- 4.4.3 Trumac Healthcare Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Trumac Healthcare Lactulose Oral Solution Product Portfolio
- 4.4.5 Trumac Healthcare Recent Developments
- 4.5 Solvay Group(Solvay Pharmaceuticals)
- 4.5.1 Solvay Group(Solvay Pharmaceuticals) Company Information
- 4.5.2 Solvay Group(Solvay Pharmaceuticals) Business Overview
- 4.5.3 Solvay Group(Solvay Pharmaceuticals) Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Solvay Group(Solvay Pharmaceuticals) Lactulose Oral Solution Product Portfolio
- 4.5.5 Solvay Group(Solvay Pharmaceuticals) Recent Developments
- 4.6 Rompharm Company
- 4.6.1 Rompharm Company Company Information
- 4.6.2 Rompharm Company Business Overview
- 4.6.3 Rompharm Company Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Rompharm Company Lactulose Oral Solution Product Portfolio
- 4.6.5 Rompharm Company Recent Developments
- 4.7 Merro Pharmaceutical
- 4.7.1 Merro Pharmaceutical Company Information
- 4.7.2 Merro Pharmaceutical Business Overview
- 4.7.3 Merro Pharmaceutical Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Merro Pharmaceutical Lactulose Oral Solution Product Portfolio
- 4.7.5 Merro Pharmaceutical Recent Developments
- 4.8 Incepta Pharmaceuticals Ltd.
- 4.8.1 Incepta Pharmaceuticals Ltd. Company Information
- 4.8.2 Incepta Pharmaceuticals Ltd. Business Overview
- 4.8.3 Incepta Pharmaceuticals Ltd. Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Incepta Pharmaceuticals Ltd. Lactulose Oral Solution Product Portfolio
- 4.8.5 Incepta Pharmaceuticals Ltd. Recent Developments
- 4.9 Illovo
- 4.9.1 Illovo Company Information
- 4.9.2 Illovo Business Overview
- 4.9.3 Illovo Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Illovo Lactulose Oral Solution Product Portfolio
- 4.9.5 Illovo Recent Developments
- 4.10 Biofac
- 4.10.1 Biofac Company Information
- 4.10.2 Biofac Business Overview
- 4.10.3 Biofac Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Biofac Lactulose Oral Solution Product Portfolio
- 4.10.5 Biofac Recent Developments
- 4.11 Aristopharma LTD
- 4.11.1 Aristopharma LTD Company Information
- 4.11.2 Aristopharma LTD Business Overview
- 4.11.3 Aristopharma LTD Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Aristopharma LTD Lactulose Oral Solution Product Portfolio
- 4.11.5 Aristopharma LTD Recent Developments
- 4.12 Arecor Therapeutics (Tetris Pharma)
- 4.12.1 Arecor Therapeutics (Tetris Pharma) Company Information
- 4.12.2 Arecor Therapeutics (Tetris Pharma) Business Overview
- 4.12.3 Arecor Therapeutics (Tetris Pharma) Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Arecor Therapeutics (Tetris Pharma) Lactulose Oral Solution Product Portfolio
- 4.12.5 Arecor Therapeutics (Tetris Pharma) Recent Developments
- 4.13 Akorn Operating Company
- 4.13.1 Akorn Operating Company Company Information
- 4.13.2 Akorn Operating Company Business Overview
- 4.13.3 Akorn Operating Company Lactulose Oral Solution Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Akorn Operating Company Lactulose Oral Solution Product Portfolio
- 4.13.5 Akorn Operating Company Recent Developments
5 Global Lactulose Oral Solution Market Scenario by Region
- 5.1 Global Lactulose Oral Solution Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lactulose Oral Solution Sales by Region: 2021-2032
- 5.2.1 Global Lactulose Oral Solution Sales by Region: 2021-2026
- 5.2.2 Global Lactulose Oral Solution Sales by Region: 2027-2032
- 5.3 Global Lactulose Oral Solution Revenue by Region: 2021-2032
- 5.3.1 Global Lactulose Oral Solution Revenue by Region: 2021-2026
- 5.3.2 Global Lactulose Oral Solution Revenue by Region: 2027-2032
- 5.4 North America Lactulose Oral Solution Market Facts & Figures by Country
- 5.4.1 North America Lactulose Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lactulose Oral Solution Sales by Country (2021-2032)
- 5.4.3 North America Lactulose Oral Solution Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Lactulose Oral Solution Market Facts & Figures by Country
- 5.5.1 Europe Lactulose Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lactulose Oral Solution Sales by Country (2021-2032)
- 5.5.3 Europe Lactulose Oral Solution Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Lactulose Oral Solution Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lactulose Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lactulose Oral Solution Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lactulose Oral Solution Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lactulose Oral Solution Market Facts & Figures by Country
- 5.7.1 South America Lactulose Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lactulose Oral Solution Sales by Country (2021-2032)
- 5.7.3 South America Lactulose Oral Solution Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Lactulose Oral Solution Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lactulose Oral Solution Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lactulose Oral Solution Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lactulose Oral Solution Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Lactulose Oral Solution Sales by Type (2021-2032)
- 6.1.1 Global Lactulose Oral Solution Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lactulose Oral Solution Sales Market Share by Type (2021-2032)
- 6.2 Global Lactulose Oral Solution Revenue by Type (2021-2032)
- 6.2.1 Global Lactulose Oral Solution Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lactulose Oral Solution Revenue Market Share by Type (2021-2032)
- 6.3 Global Lactulose Oral Solution Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lactulose Oral Solution Sales by Application (2021-2032)
- 7.1.1 Global Lactulose Oral Solution Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lactulose Oral Solution Sales Market Share by Application (2021-2032)
- 7.2 Global Lactulose Oral Solution Revenue by Application (2021-2032)
- 7.2.1 Global Lactulose Oral Solution Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lactulose Oral Solution Revenue Market Share by Application (2021-2032)
- 7.3 Global Lactulose Oral Solution Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lactulose Oral Solution Value Chain Analysis
- 8.1.1 Lactulose Oral Solution Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lactulose Oral Solution Production Mode & Process
- 8.2 Lactulose Oral Solution Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lactulose Oral Solution Distributors
- 8.2.3 Lactulose Oral Solution Customers
9 Global Lactulose Oral Solution Analyzing Market Dynamics
- 9.1 Lactulose Oral Solution Industry Trends
- 9.2 Lactulose Oral Solution Industry Drivers
- 9.3 Lactulose Oral Solution Industry Opportunities and Challenges
- 9.4 Lactulose Oral Solution Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst